ArticleNature reviews. Neurology2022
Beyond ocrelizumab in primary progressive multiple sclerosis.
Thomas Williams et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleNature reviews. Neurology2022
Thomas Williams et al.PubMed ↗Publisher ↗
No numbers read from the abstract.